ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,483 | -21.5% | 20,105 | +10.2% | 0.00% | 0.0% |
| Q2 2023 | $117,876 | +86573.5% | 18,247 | +1.0% | 0.00% | -50.0% |
| Q1 2023 | $136 | -14.5% | 18,072 | +15.5% | 0.00% | -33.3% |
| Q4 2022 | $159 | -99.9% | 15,648 | +2.6% | 0.00% | 0.0% |
| Q3 2022 | $151,000 | +38.5% | 15,246 | +48.5% | 0.00% | 0.0% |
| Q2 2022 | $109,000 | -47.1% | 10,269 | -51.4% | 0.00% | -40.0% |
| Q1 2022 | $206,000 | -32.0% | 21,109 | +39.6% | 0.01% | 0.0% |
| Q3 2021 | $303,000 | -82.7% | 15,121 | -81.0% | 0.01% | -84.8% |
| Q2 2021 | $1,754,000 | – | 79,724 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |